Protocol & Endpoint Strategy
Align modalities, acquisition rules, eligibility criteria, and image-based endpoints before the protocol is locked.
Protocol Design. Site Readiness. Expert Image Analysis.
OIRRC brings the imaging work of an ophthalmic trial into one coordinated operation—from protocol decisions and site certification to rapid image review, expert grading, and sponsor-ready outputs.
Align modalities, acquisition rules, eligibility criteria, and image-based endpoints before the protocol is locked.
Plan site qualification plus device, photographer, lane, and BCVA certification around your study timeline.
Use real-time eligibility review and early image-quality checks to prevent avoidable screening and randomization delays.
Build a grading plan with dual reads, adjudication, multimodal analysis, and validated algorithms where they add value.
Track every image, QC decision, read, query, and audit trail in a sponsor-visible workflow.
Each platform addresses a specific operational need, while OIRRC’s scientific and clinical teams keep the full imaging pathway connected.
Flags image-quality issues, supports pre-screening, and structures human review so trial teams can act sooner without removing expert oversight.
Explore ScopeAIConnects image-guided functional testing with retinal structure, giving sponsors a clearer view of how anatomical and functional change relate.
Explore IGMPStandardizes FAF-based atrophy measurement for programs that require reproducible lesion quantification and longitudinal analysis.
Explore StarGaugeGives sponsors a real-time view of image intake, QC, reads, queries, turnaround times, and audit-ready trial records.
Explore EyeSolEnables remote BCVA certification with AR-guided measurement, proctoring, and audit-ready documentation so examiners and lanes can be qualified without an in-person site visit.
Explore ClarityBring the part of your trial that needs a clear operating plan. We will work through the imaging implications with you.
Useful outcome: A clearer imaging plan and the decisions needed next.
Useful outcome: A practical readiness path for sites and study teams.
Useful outcome: Clear ownership, review points, and sponsor visibility.
AAO 2026 · New Orleans, Louisiana
Meet the OIRRC team to discuss trial timelines, imaging operations, platform capabilities, and the decisions that can protect your ophthalmic development program.
Case Study
Learn how a global biotech sponsor shortened eligibility determination while preserving expert review, adjudication, and sponsor visibility.
Tell us a bit about your program and we will send the case study along with the most relevant OIRRC follow-up for your imaging and trial-execution priorities.